Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

314
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
314
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.7K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.7K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.4K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.4K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

67
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
67
Poisson Probability Distribution01:09

Poisson Probability Distribution

12.5K
A Poisson probability distribution is a discrete probability distribution. It gives the probability of a number of events occurring in a fixed interval of time or space if these events happen at a known average rate and independently of the time since the last event. For example, a book editor might be interested in the number of words spelled incorrectly in a particular book. It might be that, on average, there are five words spelled incorrectly in 100 pages. The interval is 100 pages.
The...
12.5K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

673
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
673

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenetic tree inference from single-cell RNA sequencing data with SCITE-RNA.

Genome biology·2026
Same author

Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study.

The Lancet. Microbe·2026
Same author

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

Nature communications·2026
Same author

Learning and forecasting selection dynamics of SARS-CoV-2 variants from wastewater sequencing data using Covvfit.

Water research·2026
Same author

Corrigendum to "Characterizing Influenza A Virus Lineages and Clinically Relevant Mutations Through High-Coverage Wastewater Sequencing" [Water Research (2025) Article No. 124453].

Water research·2026
Same author

Unifying non-Markovian dynamics and agent heterogeneity in scalable stochastic networks.

Nature communications·2026
Same journal

circ2DGNN: circRNA-Disease Association Prediction via Transformer-Based Graph Neural Network.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Hierarchical Hypergraph Learning in Association- Weighted Heterogeneous Network for miRNA- Disease Association Identification.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Discriminative Domain Adaption Network for Simultaneously Removing Batch Effects and Annotating Cell Types in Single-Cell RNA-Seq.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

MLW-BFECF: A Multi-Weighted Dynamic Cascade Forest Based on Bilinear Feature Extraction for Predicting the Stage of Kidney Renal Clear Cell Carcinoma on Multi-Modal Gene Data.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

An End-to-End Knowledge Graph Fused Graph Neural Network for Accurate Protein-Protein Interactions Prediction.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Generative Biomedical Event Extraction With Constrained Decoding Strategy.

IEEE/ACM transactions on computational biology and bioinformatics·2024
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.9K

HIV Haplotype Inference Using a Propagating Dirichlet Process Mixture Model.

Sandhya Prabhakaran, Mélanie Rey, Osvaldo Zagordi

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |September 11, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a new computational method to identify human immunodeficiency virus (HIV) haplotypes from sequencing data. This technique aids in tracking drug-resistant HIV mutants for better treatment strategies.

    More Related Videos

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
    07:06

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

    Published on: December 1, 2011

    13.8K
    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    12.8K

    Related Experiment Videos

    Last Updated: Apr 4, 2026

    Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
    11:10

    Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

    Published on: December 27, 2010

    12.9K
    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
    07:06

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

    Published on: December 1, 2011

    13.8K
    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    12.8K

    Area of Science:

    • Computational biology
    • Virology
    • Genetics

    Background:

    • Human immunodeficiency virus (HIV) generates drug-resistant mutants within patients.
    • Identifying these mutants is crucial for effective HIV treatment and drug administration.
    • Deep sequencing generates short reads, posing challenges for traditional analysis.

    Purpose of the Study:

    • To develop a novel computational technique for identifying HIV haplotypes.
    • To address the statistical challenge of analyzing non-standard clustering problems with missing similarity measures in sequencing data.

    Main Methods:

    • A Dirichlet Process Mixture Model was propagated by sequentially updating prior information.
    • The method analyzes short deep sequencing reads to identify HIV mutants.
    • The computational technique was validated using both simulated and real-world sequencing data.

    Main Results:

    • The new computational technique successfully identifies HIV haplotypes from sequencing data.
    • The model effectively handles the non-standard clustering problem inherent in analyzing short sequencing reads.
    • Validation with simulated and real data confirms the technique's efficacy.

    Conclusions:

    • The presented computational method offers an effective approach for HIV haplotype identification.
    • This technique can improve the tracking of drug-resistant HIV mutants.
    • The findings contribute to advancing computational tools for viral evolution studies and personalized medicine.